Dahl, Kirsten
Novo Nordisk (Denmark)
6 papers on CoChatORCID 0000-0001-5063-1554
Most cited papers
- Verified
Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes
Gibbons, C., Blundell, J., Tetens Hoff, S., Dahl, K., Bauer, R., & Bækdal, T. (2021) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementRegulation of Appetite and Obesity
Cited by 149
- Verified
Development of Cagrilintide, a Long-Acting Amylin Analogue
Kruse, T., Hansen, J. L., Dahl, K., Schäffer, L., Sensfuss, U., Poulsen, C., Schlein, M., Hansen, A. M. K., Jeppesen, C. B., Dornonville de la Cour, C., et al. (2021) · Journal of Medicinal Chemistry
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 129
- Verified
Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes
Dahl, K., Brooks, A., Almazedi, F., Hoff, S. T., Boschini, C., & Bækdal, T. A. (2021) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 87
- Verified
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
Dahl, K., Toubro, S., Dey, S., Duque do Vale, R., Flint, A., Gasiorek, A., Heydorn, A., Jastreboff, A. M., Key, C., Petersen, S. B., et al. (2025) · The Lancet
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 80
- Verified
In Vitro CYP450 Enzyme Downregulation by GLP-1/Glucagon Coagonist Does Not Translate to Observed Drug-Drug Interactions in the Clinic
Säll, C., Alifrangis, L., Dahl, K., Friedrichsen, M. H., Nygård, S. B., & Kristensen, K. (2022) · Drug Metabolism and Disposition
Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms
Cited by 17
- Verified
Author response for "Response to the letter from Horowitz et al to the Editor relating to the publication ‘Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes’ by Dahl et al"
Dahl, K., & Bækdal, T. A. (2021) · Publons reviews and discussion
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free